Klin Padiatr 2024; 236(03): 200
DOI: 10.1055/s-0044-1786552
Evaluation of Navitoclax (ABT-263) as a promising Therapy for Pediatric Acute Myeloid
Leukemia
Authors
-
D Agha-Mir-Salim
1
Goethe University Frankfurt am Main; Germany
-
R Bhayadia
1
Goethe University Frankfurt am Main; Germany
-
D Heckl
2
Martin-Luther-University Halle-Wittenberg; Germany
-
J H Klusmann
1
Goethe University Frankfurt am Main; Germany
